Overview of Dr. Matushansky
Dr. Igor Matushansky is an oncologist in New York, NY and is affiliated with New York-Presbyterian Hospital. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 16 years. Dr. Matushansky accepts several types of health insurance, listed below. He is one of 379 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 20 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032Fax+1 212-305-6891
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2003
Albert Einstein College of MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2003 - 2026
Clinical Trials
- A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients Start of enrollment: 2018 Dec 12
- A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers Start of enrollment: 2019 Dec 11
Publications & Presentations
PubMed
- 148 citationsDerivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathwayIgor Matushansky, Eva Hernando, Nicholas D. Socci, Joslyn Mills, Tulio Matos
The Journal of Clinical Investigation. 2007-11-01 - 12 citationsDevelopment and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform.Henning Lauterbach, Sarah Schmidt, Kia Katchar, Xiaoping Qing, Corinne Iacobucci
Frontiers in Oncology. 2021-10-14 - 100 citationsTerminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.Xi Zhang, Filemon S. Dela Cruz, Melissa Terry, Fabrizio Remotti, Igor Matushansky
Oncogene. 2013-05-02
Press Mentions
HOOKIPA and DarwinHealth Enter into a Research Collaboration and License Agreement to Discover and Prioritize Novel Immunogenic, Tumor-Specific Cryptic AntigensNovember 28th, 2018
Crescendo Names Ex-Roche Leader Pisa as CMOSeptember 11th, 2018
Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa BiotechMarch 6th, 2017
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS North Carolina BlueOptions PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOGreat West PPO
HIP of New York - Select PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
